IL144645A0 - Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid - Google Patents

Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid

Info

Publication number
IL144645A0
IL144645A0 IL14464500A IL14464500A IL144645A0 IL 144645 A0 IL144645 A0 IL 144645A0 IL 14464500 A IL14464500 A IL 14464500A IL 14464500 A IL14464500 A IL 14464500A IL 144645 A0 IL144645 A0 IL 144645A0
Authority
IL
Israel
Prior art keywords
fatty acid
nutritional supplement
carbon fatty
triglycerides
pharmaceutical preparation
Prior art date
Application number
IL14464500A
Other languages
English (en)
Original Assignee
Baylor University Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor University Medical Ct filed Critical Baylor University Medical Ct
Publication of IL144645A0 publication Critical patent/IL144645A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL14464500A 1999-02-05 2000-02-03 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid IL144645A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11903899P 1999-02-05 1999-02-05
PCT/US2000/003022 WO2000045649A1 (en) 1999-02-05 2000-02-03 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid

Publications (1)

Publication Number Publication Date
IL144645A0 true IL144645A0 (en) 2002-05-23

Family

ID=22382253

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14464500A IL144645A0 (en) 1999-02-05 2000-02-03 Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid

Country Status (14)

Country Link
EP (1) EP1150579B1 (de)
JP (2) JP4902906B2 (de)
KR (1) KR100702823B1 (de)
CN (2) CN101574335A (de)
AT (1) ATE303079T1 (de)
AU (1) AU775708C (de)
CA (1) CA2361070C (de)
DE (1) DE60022312T2 (de)
HK (1) HK1042412B (de)
HU (1) HUP0200511A3 (de)
IL (1) IL144645A0 (de)
MX (1) MXPA01007988A (de)
NZ (1) NZ513329A (de)
WO (1) WO2000045649A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003160486A (ja) * 2001-09-17 2003-06-03 Lion Corp 経口養育毛剤及び該養育毛剤を含有する飲食品
AU2003261928A1 (en) * 2002-09-05 2004-03-29 The Nisshin Oillio Group, Ltd. Agents, foods and drinks controlling lipid metabolism
WO2004022049A1 (ja) * 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. 痩身剤およびその飲食物
WO2004022051A1 (ja) * 2002-09-05 2004-03-18 The Nisshin Oillio Group, Ltd. ペルオキシソーム増殖薬活性化受容体調整剤
EP1773317A4 (de) * 2004-07-02 2012-10-03 Baylor Res Inst Verfahren zur behandlung von glycogen-oder polysaccharid-speicherkrankheit
EP1929995A1 (de) 2006-12-04 2008-06-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Anaplerotische Therapie der Huntington-Krankheit und anderer Polyglutamin-Erkrankungen
DE102008057867A1 (de) * 2008-11-18 2010-05-20 B. Braun Melsungen Ag Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten
JP2013528648A (ja) * 2010-06-14 2013-07-11 ベイラー リサーチ インスティテュート 成人ポリグルコサン小体病（ａｐｂｄ）を処置するためのトリヘプタノイン食
GB201210699D0 (en) * 2012-06-15 2012-08-01 Vitaflo Ltd Nutritional food
CA2894456C (en) 2012-12-13 2022-06-28 Baylor Research Institute Triheptanoin for the treatment of glucose transporter 1 deficiency
ES2774321T3 (es) 2013-11-14 2020-07-20 Univ Queensland Trastornos neurodegenerativos y métodos de tratamiento y diagnóstico de los mismos
CN105764497A (zh) * 2013-11-14 2016-07-13 奥特吉尼克斯制药公司 三酸甘油酯的固体组合物及其用途
JP7032027B2 (ja) * 2015-11-06 2022-03-08 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア 脂肪酸代謝障害の治療を目的とした組成物および方法
WO2020014428A1 (en) 2018-07-11 2020-01-16 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method of treating fatty acid oxidation disorders using omega3/omega6 unsaturated or branched chain fatty acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5215834A (en) * 1975-07-12 1977-02-05 Ajinomoto Kk Method of producing food composition
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
US5153221A (en) * 1990-10-05 1992-10-06 Elena Avram Method for the treatment of acquired immune deficiency syndrome
US5569675A (en) * 1994-03-07 1996-10-29 Bar Ilan University Methods of using carboxylic acid esters to increase fetal-hemoglobin levels
DE4439947A1 (de) * 1994-11-09 1996-05-15 Boehringer Mannheim Gmbh 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AU733714B2 (en) * 1996-08-27 2001-05-24 Hemosol Inc. Enhanced stimulation of erythropoiesis
US5908631A (en) * 1997-02-27 1999-06-01 L'oreal S.A. Monohydric alcohol-free composition for topical use comprising solubilized ethylcellulose

Also Published As

Publication number Publication date
HUP0200511A3 (en) 2003-03-28
CA2361070A1 (en) 2000-08-10
CN101574335A (zh) 2009-11-11
NZ513329A (en) 2003-11-28
JP2012082202A (ja) 2012-04-26
CN1345188A (zh) 2002-04-17
HUP0200511A2 (en) 2002-06-29
AU775708C (en) 2005-07-14
JP5553815B2 (ja) 2014-07-16
EP1150579B1 (de) 2005-08-31
WO2000045649A1 (en) 2000-08-10
KR100702823B1 (ko) 2007-04-06
HK1042412B (en) 2006-01-06
EP1150579A1 (de) 2001-11-07
CA2361070C (en) 2012-04-17
HK1042412A1 (en) 2002-08-16
ATE303079T1 (de) 2005-09-15
JP2002536304A (ja) 2002-10-29
DE60022312T2 (de) 2006-07-06
AU3223600A (en) 2000-08-25
KR20010108173A (ko) 2001-12-07
AU775708B2 (en) 2004-08-12
JP4902906B2 (ja) 2012-03-21
CN100408031C (zh) 2008-08-06
MXPA01007988A (es) 2003-07-14
DE60022312D1 (de) 2005-10-06

Similar Documents

Publication Publication Date Title
IL144645A0 (en) Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
Jensen The composition of bovine milk lipids: January 1995 to December 2000
EP2218342A3 (de) Neue Diätetische zusammensetzungen und deren Verwendung
TW360501B (en) Dietetically balanced milk product
MY112705A (en) Tryglycerides
NZ299464A (en) Use of gamma linolenic or dihomogamma linolenic acid in the treatment of Huntington's Chorea
HUP9903791A3 (en) Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters,process for preparing the same and their use in medicaments
CA2268257A1 (en) Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
ZA200004725B (en) Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria.
DE69927125D1 (de) Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels
AU9164198A (en) Use of organic acid esters in dietary fat
WO2001017517A3 (en) Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer
WO2001019356A3 (en) High lipid diet
CA2004332A1 (en) Inhibition of cell adhesion
AU1145483A (en) Linoleic acid and essential fatty acid compositions as
WO2005062713A3 (en) Beta vulgaris-based products
AU5018900A (en) Lipid metabolism transcription factor
PL1799204T3 (pl) Kompozycja zawierająca kwasy tłuszczowe omega-3 i omega-6
CN201207848Y (zh) 一种宠物笼
EP1129711A3 (de) Pinolensäure gegen Diabetes
DK1235835T3 (da) Chrom-histidinkomplekser som ernæringstilskud
CA2162042A1 (en) Enteral Nutritional Product
CA2335713A1 (en) Oral dosage form
EP1269991A3 (de) Topische Zusammensetzung die Ethyllinoleat und/oder Triethylzitrat mit Synergisten
AU6095399A (en) Food composition based on substance derived from milk comprising conjugate linoleic acid glycerides

Legal Events

Date Code Title Description
ERR Corrigendum

Free format text: JOURNAL NO. 11/2004 P. 3654 PATENT APPLICATION NO. 144645 CORRECT THE NAME OF APPLICANT TO- BAYLOR RESEARCH INSTITUTE

FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired